Related content

Pharmacogenomics: implications and considerations for pharmacists

By Brock Tina Penick   Valgus John M   Smith Scott R   Summers Kelly M  

Pharmacogenomics, Vol. 4, Iss. 3, 2003-05 ,pp. : 321-330

Future Medicine

Access to resources Recommend Favorite

Implications of the incidentalome for clinical pharmacogenomics

By Brothers Kyle B   Langanke Martin   Erdmann Pia  

Pharmacogenomics, Vol. 14, Iss. 11, 2013-08 ,pp. : 1353-1362

Future Medicine

Access to resources Recommend Favorite

Pharmacogenomics—Clinical and Social Implications

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 33, Iss. 3, 2003-09 ,pp. : 224-227

John Wiley & Sons Inc

Access to resources Recommend Favorite

Genetics of Hypertension: Therapeutic Implications

By O’Byrne S.   Caulfield M.  

Drugs, Vol. 56, Iss. 2, 1998-08 ,pp. : 203-214

Adis International

Access to resources Recommend Favorite

Implications of dihydropyrimidine dehydrogenase on 5-fluorouracil pharmacogenetics and pharmacogenomics

By Mattison Lori K   Soong Richie   Diasio Robert B  

Pharmacogenomics, Vol. 3, Iss. 4, 2002-07 ,pp. : 485-492

Future Medicine

Access to resources Recommend Favorite